Clarifying the role of ALK1 in the regulation of angiogenesis and the downstream signaling pathway of ALK1 would enhance our understanding of the mechanisms underlying AVM formation in HHT2 patients. This evidence concerns the gene ACVRL1 and telangiectasia, hereditary hemorrhagic, type 2.